FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Cardiac Ablation Percutaneous Catheter

PMA: P930029 · Supplement: S066 · Decision Jul 23, 2020
Classifications
1
FEI Numbers
52
Registration Numbers
52

Basic Information

Device Name
Cardiac Ablation Percutaneous Catheter
Trade Name
RF Conductr, RF Contactr, RF Marinr, RF Enhancr II
PMA Number
P930029
Supplement Number
S066
Device Class
FDA Class 3
Product Code
LPB
Generic Name
Cardiac ablation percutaneous catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
July 23, 2020
Date Received
July 2, 2020
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Transfer the incoming inspection process SEM/EDS and FTIR testing activities to the MPROC Juncos facility laboratories.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LPB Cardiac Ablation Percutaneous Catheter